BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37134173)

  • 1. Multiplexed selectivity screening of anti-GPCR antibodies.
    Dahl L; Kotliar IB; Bendes A; Dodig-Crnković T; Fromm S; Elofsson A; Uhlén M; Sakmar TP; Schwenk JM
    Sci Adv; 2023 May; 9(18):eadf9297. PubMed ID: 37134173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Makes Antibodies Against G Protein-Coupled Receptors so Special? A Novel Concept to Understand Chronic Diseases.
    Riemekasten G; Petersen F; Heidecke H
    Front Immunol; 2020; 11():564526. PubMed ID: 33384684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges.
    Ayoub MA; Crépieux P; Koglin M; Parmentier M; Pin JP; Poupon A; Reiter E; Smit M; Steyaert J; Watier H; Wilkinson T
    MAbs; 2017 Jul; 9(5):735-741. PubMed ID: 28475474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed analysis of the secretin-like GPCR-RAMP interactome.
    Lorenzen E; Dodig-Crnković T; Kotliar IB; Pin E; Ceraudo E; Vaughan RD; Uhlèn M; Huber T; Schwenk JM; Sakmar TP
    Sci Adv; 2019 Sep; 5(9):eaaw2778. PubMed ID: 31555726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
    van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
    Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
    Elife; 2020 Feb; 9():. PubMed ID: 32096468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.
    Park JY; Lee SY; Kim HR; Seo MD; Chung KY
    Arch Pharm Res; 2016 Mar; 39(3):293-301. PubMed ID: 26825061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed profiling of GPCR activities by combining split TEV assays and EXT-based barcoded readouts.
    Galinski S; Wichert SP; Rossner MJ; Wehr MC
    Sci Rep; 2018 May; 8(1):8137. PubMed ID: 29802268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
    De Groof TWM; Bobkov V; Heukers R; Smit MJ
    Mol Cell Endocrinol; 2019 Mar; 484():15-24. PubMed ID: 30690070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.
    Rahman MM; Islam MR; Mim SA; Sultana N; Chellappan DK; Dua K; Kamal MA; Sharma R; Emran TB
    Oxid Med Cell Longev; 2022; 2022():8425640. PubMed ID: 36187336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering therapeutic antibodies targeting G-protein-coupled receptors.
    Jo M; Jung ST
    Exp Mol Med; 2016 Feb; 48(2):e207. PubMed ID: 26846450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology of G protein-coupled receptor signaling complexes.
    Edward Zhou X; Melcher K; Eric Xu H
    Protein Sci; 2019 Mar; 28(3):487-501. PubMed ID: 30311978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biasing GPCR signaling from inside.
    Shukla AK
    Sci Signal; 2014 Jan; 7(310):pe3. PubMed ID: 24473194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.
    Kapolka NJ; Taghon GJ; Rowe JB; Morgan WM; Enten JF; Lambert NA; Isom DG
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13117-13126. PubMed ID: 32434907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structural Life Science towards the Regulation of Selective GPCR Signaling].
    Kobayashi T
    Yakugaku Zasshi; 2016; 136(2):179-84. PubMed ID: 26831790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the GPCR-RAMP interactome.
    Kotliar IB; Bendes A; Dahl L; Chen Y; Saarinen M; Ceraudo E; Dodig-Crnković T; Uhle'n M; Svenningsson P; Schwenk JM; Sakmar TP
    bioRxiv; 2023 Nov; ():. PubMed ID: 38045268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an Antigen-Antibody Co-Display System for Detecting Interaction of G-Protein-Coupled Receptors and Single-Chain Variable Fragments.
    Zhang Y; Wu BJ; Yu X; Luo P; Ye H; Yu Y; Han W; Li J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of GPCR dimerisation/oligomerisation in receptor signalling.
    Milligan G; Canals M; Pediani JD; Ellis J; Lopez-Gimenez JF
    Ernst Schering Found Symp Proc; 2006; (2):145-61. PubMed ID: 17703581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
    Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.